The results showed much smaller tumor volume observed in Arhgef11-KO groups than the control group (Fig. 5i, j), suggesting copy-number gain of Arhgef11 is a tumor driving event and Arhgef11 plays an oncogene role in tumor progression. The gene discussed is ARHGEF11; the disease is neoplasm.